The FTC is not anti-direct selling. It’s pro-truth in advertising.
The DSA misses the mark.
Lehr et al. v. Cryo-Cell International, Inc.
23-cv-80405, S.D. Fla.
(Jan. 2023)
Umbilical cord blood banking program
Deceptively marketing that stored cord blood can treat at least 80 serious medical conditions without disclosing that the FDA has approved the use of cord blood to treat only 7 medical conditions and that the odds of being able to use cord blood for treatment is “virtually zero”
Pending
The DSA misses the mark.
TINA.org reader takes issue with this product’s deceptive packaging.
Don’t let this company blindside you with its deceptive pricing.
Lawsuit pokes holes in company’s Swiss branding.
Why are these airport vendors slyly charging consumers for “employee benefits”?